OR WAIT null SECS
Astrid Weins, MD, PhD, is the chief of integrated renal pathology at Mass General Brigham.
November 18, 2026
Video
Sparsentan, B cell therapies, and TRPC6 and APOL1 inhibitors may each fit a different stage and cause of FSGS.
A renal pathologist explains how biopsy findings, clinical context, anti-nephrin antibodies and genetics shape FSGS workup.